APA (7th ed.) Citation

Yang, T., Dong, Y., Zhang, M., Feng, J., Fu, S., Xiao, P., . . . Hu, Y. (2025). Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia. Experimental Hematology & Oncology, 14(1), 1. https://doi.org/10.1186/s40164-024-00593-5

Chicago Style (17th ed.) Citation

Yang, Tingting, et al. "Prominent Efficacy and Good Safety of Sequential CD19 and CD22 CAR-T Therapy in Relapsed/refractory Adult B-cell Acute Lymphoblastic Leukemia." Experimental Hematology & Oncology 14, no. 1 (2025): 1. https://doi.org/10.1186/s40164-024-00593-5.

MLA (9th ed.) Citation

Yang, Tingting, et al. "Prominent Efficacy and Good Safety of Sequential CD19 and CD22 CAR-T Therapy in Relapsed/refractory Adult B-cell Acute Lymphoblastic Leukemia." Experimental Hematology & Oncology, vol. 14, no. 1, 2025, p. 1, https://doi.org/10.1186/s40164-024-00593-5.